This therapeutic antibody drug development webinar, discusses the idea of limiting the substantial investment of time, money, or resources. If you choose the right analytical tools to help make smarter decisions. We highlight why our Prometheus instrument using nanoDSF technology will help to make quantitative, data-driven solutions to help accelerate the therapeutic antibody drug development. Have a listen if you’re a curious scientist who loves learning about new technologies and how they can help make research more efficient!
How do you usually know whether your protein is happy? Even if you’re already using a portfolio of techniqu...
Most recent content
Neurodegenerative diseases like Alzheimer’s or Parkinson’s Disease affect millions of people worldwide. Although current treatments may help relieve some of the physical or mental symptoms, there is s
Pandemics have affected human society throughout history, but with the current pandemic happening today, realization is quickly setting in just how much viral infectious diseases impact everyday life.
Gene therapy—a type of DNA-based medicine that utilizes a virus to insert a healthy gene into cells to replace a mutated, disease-causing variant has emerged as one of the most promising medical treat
How do you usually know whether your protein is happy? Even if you’re already using a portfolio of techniques to check, you may not have all the info. Find out how to use Tycho to really understand wh
A big hurdle in small molecule drug discovery screening is confidently identifying positive hits in a timely manner. Screening fragment libraries is challenging with current methodologies that are eit
Vaccines are biological products derived from living organisms that provide an immune response to pathogens or diseases.While research efforts in developing vaccines continue to increase, scientists
Cellular expression and purification of proteins are among the most widely used techniques in biology. Expressing proteins in stable, properly-folded states is a challenge that may be abated by monito
Process development for Fill & Finish activities of large molecule parenterals requires an orchestrated effort of multiple functions to deal with product specific critical quality attributes (CQAs) an
Analyzing large amounts of experimental data is as big a bottleneck in your workflow as running the experiments themselves. Struggling through manual manipulation of data or complex third-party softwa
Influenza A virus (IAV) utilizes a multivalent binding strategy to the host cell, binding its trimeric spike protein hemagglutinin (HA) to sialic acid present on the cellular membrane. For this reason
Indoleamine 2,3 dioxygenase 1 (IDO1) is an heme-containing enzyme that catalyses the conversion of L-Tryptophan (Trp) into a series of bioactive metabolites along the kynurenine pathway, eventually le
The stability of enzymatic biocatalysts is of primary importance in the biotechnology, food, chemical, and pharmaceutical industries, but screening for biocatalyst stability has been a long-standing c
The involvement of the immune system in tumor control is becoming well understood. The tumor environment is in a state of equilibrium between the elimination of cancer cells by the immune system and t
Ribosomes are massive macromolecular complexes composed of proteins and RNAs andperform one of the most fundamental processes in all living cells—the synthesis of proteins. The binding interactions an